| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |